While on these schedules, most either continued to lose small amounts of weight or maintained their weight
[9] Furthermore, in the phase 3 randomized, placebo-controlled 3-year SURMOUNT-1 trial for people with obesity and prediabetes, tirzepatide compared with placebo resulted in substantial and sustained weight reduction (1523% vs 2%), significant reduction in HbA1c (0.500.65% vs 0.14%), as well as a 94% reduction in risk of progression to T2D [10]
271 , R848R856 (1996)
Advertisement Image Credit: Ridofranz / iStock.7
International Journal of Oncology, 20 (1), 6975
MIC B12 injection therapy may be right for eligible adults who are looking for provider-guided support related to energy, metabolism, wellness routines, or nutritional support